PRIVACY NOTICE TO PARTICIPANTS: Immunization of women with diphtheria and tetanus toxoids combined with acellular pertussis (Tdap) during the mid third trimester of pregnancy: an evaluation of the potential for immunological protection for the neonate
Participants needed:
Privacy Notice for volunteers who participated in the clinical trial entitled: Immunization of women with diphtheria… Read More»
Learn More About This StudyUnderstanding the effects of public health outbreak control policies and implementation on individuals and communities: A path to improving COVID-19 policy effectiveness
Participants needed: Seniors and COVID-19 patients and their families
We are inviting you to participate in a focus group to discuss your experiences during the COVID-19 pandemic and how the COVID-19 public health measures affected you.
Learn More About This StudyPhase 3 Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
Participants needed: 16-40 years old, female
The purpose of this clinical trial is to evaluate the safety and effectiveness of an investigational vaccine against cytomegalovirus (CMV) infection in women who have not had prior CMV infection and evaluate its safety in women who test positive for CMV due to prior exposure.
Learn More About This StudyControlled Human Infection Model (pertussis)
Participants needed: Ages 18-40
CCfV is looking for healthy adult volunteers to participate in Canada’s first human challenge trial to better understand pertussis (whooping cough)
Learn More About This Study